Racial differences in the treatment of early-stage lung cancer

New England Journal of Medicine

Volumn 341, Issue 16, 1999, Pages 1198-1205

  Bach, Peter B ^a,b,d   Cramer, Laura D ^a   Warren, Joan L ^c   Begg, Colin B ^a  

^a Dept of Epidemiol and Biostatist ^*  (United States)

^b Pulmonary Division   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; TREATMENT OUTCOME;

CANCER; CLINICAL APPROACH/SOURCE; EMPIRICAL APPROACH; MEDICARE; PROFESSIONAL PATIENT RELATIONSHIP; SELECTION FOR TREATMENT; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MEDICARE; PATIENT SELECTION; PNEUMONECTOMY; SEER PROGRAM; SOCIAL CLASS; SURVIVAL RATE; UNITED STATES;

EID: 0033554709     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199910143411606     Document Type: Review

References (30)

1. Lin AY, Ihde DC. Recent developments in the treatment of lung cancer. JAMA 1992;267:1661-4.
2. Greenwald HP, Polissar NL, Borgatta EF, McCorkle R, Goodman G. Social factors, treatment, and survival in early-stage non-small cell lung cancer. Am J Public Health 1998;88:1681-4.
3. Smith TJ, Penberthy L, Desch CE, et al. Differences in initial treatment patterns and outcomes of lung cancer in the elderly. Lung Cancer 1995; 13:235-52.
4. Samet JM, Hunt WC, Key CR, Humble CG, Goodwin JS. Choice of cancer therapy varies with age of patient. JAMA 1986;255:3385-90.
5. Riley GF, Potosky AL, Klabunde CN, Warren JL, Ballard-Barbash R. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA 1999;281:720-6.
6. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998;280: 1747-51.
7. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31:732-48.
8. Percy C, Van Holten V, Muir C, eds. International classification of diseases for oncology. 2nd ed. Geneva: World Health Organization, 1990.
9. Ettinger DS, Cox JD, Ginsberg RJ, et al. NCCN Non-Small Cell Lung Cancer Practice Guidelines. Oncology 1996;10:Suppl:S81-S111.
10. Mountain CE A new international staging system for lung cancer. Chest 1986;89:Suppl:225S-233S.
11. Idem. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-7.
12. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46:1075-9.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
14. Hammond JR. Substate district, HSA, and PSRO area designations. Am J Public Health 1976;66:788-90.
15. Ballard Barbash R, Potosky AL, Harlan LC, Nayficld SG, Kessler LG. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996;88:716-26.
16. Schlesselman JJ, Stolley PD. Case-control studies: design, conduct, analysis. New York: Oxford University Press, 1982.
17. Collett D. Modelling survival data in medical research. London: Chapman & Hall, 1994.
18. Shields TW. Surgical therapy for carcinoma of the lung. Clin Chest Med 1993;14:121-47.
19. Lam WK. Management of non-small cell lung cancer according to staging - an update. Respirology 1998;3:51-4.
20. National Center for Health Statistics. U.S. decennial life tables for 1989-1991. Vol. 1. No. 1. Washington, D.C.: Government Printing Office, 1997.
21. Ries LAG, Kosary CL, Hankey BF, Miller BA, Harras A, Edwards BK, eds. SEER cancer statistics review: 1973-1994. Bethesda, Md.: National Cancer Institute, 1997. (NIH publication no. 97-2789.)
22. Wingo PA, Ries LAG, Giovino GA, et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 1999;91:675-90.
23. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of census-based methodology. Am J Public Health 1992;82:703-10.
24. Dale W, Vijayakumar S, Lawlor EF, Merrell K. Prostate cancer, race, and socioeconomic status: inadequate adjustment for social factors in assessing racial differences. Prostate 1996;29:271-81.
25. Gillum RF. Chronic obstructive pulmonary disease in blacks and whites: mortality and morbidity. J Natl Med Assoc 1990;82:417-28.
26. Culler SD, Parchman ML, Przybylski M. Factors related to potentially preventable hospitalizations among the elderly. Med Care 1998;36:804-17.
27. Wennberg J, Gittelsohn A. Small area variations in health care delivery. Science 1973;182:1102-8.
28. McNeil BJ, Weichselbaum R, Pauker SG. Fallacy of the five-year survival in lung cancer. N Engl J Med 1978;299:1397-401.
29. Aday LA. Economic and noneconomic barriers to the use of needed medical services. Med Care 1975;13:447-56.
30. Schulman KA, Berlin JA, Harless W, et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med 1999;340:618-26.